Mayo Clinic Laboratory and Pathology Research Roundup: December 19

By Sarah Jarvis • December 19, 2023

Share this:

The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.

Featured Abstract

Postoperative radiation therapy for thymic carcinoma: An analysis of the ITMIG/ESTS database.

R0 resection and radiation therapy have been associated with improved overall survival (OS) in patients with thymic carcinoma (TC). Here, we analyzed which subgroups of patients derive the greatest benefit from postoperative radiation therapy (PORT).

Read more.

Published to PubMed This Week

• Phosphorylation of MIF by PIP4K2a is necessary for cilia biogenesis.
  Cell Death & Disease
• Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case.
  Virchows Archiv
• Predicting cardiopulmonary rrrest with digital biomarkers: A systematic review.
  Journal of Clinical Medicine
• The role of gene fusions in thymic epithelial tumors.
  Cancers
• Smartphone sensor data estimate alcohol craving in a cohort of patients with alcohol-associated liver disease and alcohol use disorder.
  Hepatology Communications
• Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old.
  Journal of Neuropathology and Experimental Neurology
• Ethical and legal obligations for research involving pregnant persons in a post-Dobbs context.
  The Journal of Law, Medicine, and Ethics

Sarah Jarvis

Sarah Jarvis is a Senior Marketing Specialist at Mayo Clinic Laboratories. She supports marketing strategies for paid media.